Introducing Peptide Bioregulators ‘Made in USA

Contents

Introducing Peptide Bioregulators 'Made in USA

Send on email

California-based company PEPTS USA has launched a new line of peptide bioregulators consisting of five innovative products onto the American market. These new releases, based on short peptides from IPH, have successfully passed registration with the FDA (confirming safety and efficacy). The first product line includes four primary short peptides manufactured in Japan: IPH T peptide (thymus peptide), IPH AVN peptide (vascular peptide), IPH AEN peptide (cartilage peptide), and IPH AGAA peptide (muscle peptide).

Anticipated to debut in the Russian market in spring 2022, the estimated offering price for consumers is $150 per package. The products will be available on major domestic platforms.

For researchers

Results of the experimental study properties of the peptide IPH AEN as a means to normalize the functions of bone and cartilage

For health care professionals

The Effect of the Peptide AGAA on the Proliferation of Muscle Cells of Human

For public

The Process of Peptide Synthesis in the Body from Food Sources and a List of Foods Containing Peptides